Cipla Medpro South Africa (Pty) Limited (“Cipla Medpro”), wholly owned subsidiary of Cipla Limited, India (“Cipla”), and South Africa’s fourth-largest pharmaceutical company in the private sector, has announced its plans to acquire a 100% stake in Mirren (Pty) Limited (“Mirren”).
Mirren is a South African over-the-counter (OTC) pharmaceutical manufacturer and distributor, which has been in operation for 35 years. The transaction is subject to the approval by the Competition Commission of South Africa.
Paul Miller, CEO of Cipla South Africa, said that once approved, the transaction will enhance Cipla’s current OTC portfolio, by adding Mirren’s well-established brands such as Broncol cough syrup, Coryx, Tensopyn, and Ultimag. This deal will also increase Cipla’s local manufacturing footprint.
Looking for a affordable Medical Aid or Hospital Plan, just click here Continue reading…